Senhwa Biosciences Signs AI-Driven Drug Development Partnership with CellType
Senhwa Biosciences has signed a strategic MOU with Y Combinator-backed biotech firm CellType to integrate AI into the development of its oncology drug CX-4945, aiming to expand its therapeutic potential and accelerate clinical progress.